Blog

Fujifilm Expands Fill/Finish Services To Include Late Phase Gene Therapies And Vaccines – Pharmaceutical Processing

Fujifilm Expands Fill/Finish Services To Include Late Phase Gene Therapies And Vaccines
Pharmaceutical Processing
Fujifilm Diosynth Biotechnologies (Fujifilm), a contract development and manufacturing organization (CDMO) with experience in recombinant biopharmaceuticals and gene therapies, has announced the extension of its gene therapy and viral vaccine fill

2018-05-29 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.